Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Clinical Cardiology|January 1, 1997
Creatine kinase isoforms as circulating markers of deterioration in idiopathic dilated cardiomyopathyM Hossein-Nia, K Baig, J H Goldman, et al.Lancet (London, England)|May 11, 1991
Organ-specific cardiac antibodies: serological markers for systemic hypertension in autoimmune polyendocrinopathyA L Caforio, R Wagner, J S Gill, et al.Journal of Cardiac Failure|December 1, 1995
Prognosis of idiopathic dilated cardiomyopathyP J Keeling, J H Goldman, A K Slade, et al.British Heart Journal|May 1, 1995
Familial dilated cardiomyopathy in the United KingdomP J Keeling, Y Gang, G Smith, et al.Journal of Clinical Pathology|February 16, 2000
Autoimmune markers are undetectable in end stage idiopathic dilated cardiomyopathyN de Leeuw, W J Melchers, D J Ruiter, et al.Heart (British Cardiac Society)|January 1, 1997
Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progressionA L Caforio, J H Goldman, M K Baig, et al.Lancet (London, England)|September 17, 1994
Evidence from family studies for autoimmunity in dilated cardiomyopathyA L Caforio, P J Keeling, E Zachara, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 22, 2000
Sulfinpyrazone reduces cyclosporine levels: a new drug interaction in heart transplant recipientsA L Caforio, A Gambino, F Tona, et al.The Journal of Cardiovascular Surgery|December 1, 1994
Mid-term results of heart transplantation in diabetic patientsU Livi, A L Caforio, G Grassi, et al.Tissue Antigens|May 1, 1992
Idiopathic dilated cardiomyopathy: lack of association between circulating organ-specific cardiac antibodies and HLA-DR antigensA L Caforio, M Martinetti, G Schwarz, et al.Pageof 4